Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Fig. 1

Time course of FMD measured at rest and after I/R injury in patients administered dapagliflozin (circle) or glibenclamide (square). Graphs A and B plot resting (a) and post I/R (b) curves in both study arms during the prerandomization phase. Graphs c and d show resting FMD curves for the dapagliflozin (c) and glibenclamide (d) arms before and after 12 weeks of treatment. Graphs e and f show post-I/R FMD curves for the dapagliflozin (e) and glibenclamide (f) arms before and after 12 weeks of treatment

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840